Your session is about to expire
← Back to Search
Surgery + HIPEC for Ovarian Cancer
Study Summary
This trial is testing a treatment for women with a certain type of ovarian cancer that has come back. The treatment is surgery to remove as much of the cancer as possible, followed by a heated chemotherapy treatment.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2008 Phase 3 trial • 30 Patients • NCT00052962Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are allergic to any of the ingredients in cisplatin.Your total bilirubin level should be less than 1.5 mg/dL.I have another cancer type, but it won't affect this cancer treatment's safety or results.I can take care of myself but might not be able to do heavy physical work.I have had chemotherapy directly into my abdomen before.Your liver function tests should be within a certain range, which shows that your liver is working well.Your white blood cell count is above 1,500 per microliter.I finished my last chemotherapy or radiation more than 2 weeks ago, except for bevacizumab which was over 6 weeks ago.I do not have any severe illnesses or social situations that would stop me from following the study's requirements.My organs and bone marrow are functioning well, as tested within the last 30 days.I have moderate to severe hearing loss or ringing in my ears.I am 18 years old or older.You are currently getting or have recently gotten a treatment that is still being tested and not approved by the authorities.Your creatinine level in the blood is less than 1.5 mg/dL.Your platelet count is higher than 100,000 per microliter.My cancer is mucinous and started outside the reproductive organs.I have had a transplant from a donor.My ovarian cancer, which has come back, is confirmed to be mucinous.I am not pregnant or nursing.I have large tumors outside my belly area.I have active cancer spread to my brain.I have moderate to severe numbness, tingling, or pain in my hands or feet.
- Group 1: Cytoreductive surgery
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently enrolled in this research program?
"Accurate. Clinicaltrials.gov verifies that 30 participants are actively being sought for this trial, which was first published on January 7th 2022 and updated most recently July 28th of the same year. There is one site requiring recruitment efforts."
Are there any vacancies still available for potential participants of this research study?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is actively seeking participants and was initially posted on July 1st 2022 with the latest update occuring in late July. A total of 30 patients will be enrolled at one centre."
Are there any risks associated with this therapeutic intervention?
"A rating of 2 has been assigned to this therapeutic intervention, as it is currently at the Phase 2 stage. This suggests that there are some safety data available, but no efficacy data has yet been documented."
Share this study with friends
Copy Link
Messenger